Pharma Journalist

Targeted Intracellular Delivery Summit
2023-03-08 - 2023-03-09 | Hilton Boston Back Bay, 40 Dalton St, Boston, MA, 02115, United States
Achieve Therapeutic Localization with Selective, Effective & Validated Delivery to Intracellular Targets
Optimize Your Pipeline’s Therapeutic Index with Novel Delivery Systems to Overcome Endosomal Barriers in Target Cells
Selective cell entry, biological barriers and complexities in targeting chemistry have long restricted the ability of promising drug candidates to impactfully engage their intracellular sites of action without off-target toxicity implications.
Fast forward to 2023, advances in nanomedicine technology, the LNP enabled mRNA vaccine and emphasis on personalized medicine has triggered significant pipeline shifts towards complex nucleic-acid and biologic candidates. This clinical translation depends on novel delivery systems accessing previously elusive intracellular compartments. This is further evidenced by AstraZeneca, Boehringer Ingelheim and Eli Lilly’s announcements of prioritized strategic investment in targeted intracellular delivery technologies.
At such a pivotal moment for the industry, the Targeted Intracellular Delivery Summit arrives to bring Formulation, Chemistry, Delivery & Biology industry professionals to the forefront of cutting-edge science critical to accelerate pharmaceutical R&D. Join 80+ senior leaders to explore target identification, tissue delivery, engineering technologies, endosomal escape, delivery validation analytics and more.
This is your definitive meeting for unpresented data, unrivalled insights and unmissable methodologies across the next-generation nano-platforms including LNPs, EVs, Liposomes & more, creating new opportunities for the development of safer and efficacious oligonucleotide, siRNA, mRNA, DNA delivery and protein payloads.
Unleash the true potential of your pipeline by gaining the best picture of industry’s fast-paced nano-platform progress this March!
To know more visit: https://ter.li/i23a5q

2nd Next Generation Kinase Inhibitors Summit
2023-02-22 - 2023-02-23 | Boston Park Plaza, 50 Park Plaza, Boston, MA, 02116, United States
Since Kinase inhibitors have proven to be efficacious and approvable targets, fuelling recent investment into this exciting space as their therapeutic targeting is explored beyond oncology. However, increasing resistance to existing programs and safety bottlenecks threaten further progress. The next wave of kinase targets depends on innovation.
Join the 2nd Next Generation Kinase Inhibitors Summit to connect with experts across discovery, R&D, and clinical medicine to discuss how to accelerate the next generation of kinase inhibitor drugs to market, which displays maximal therapeutic efficacy and durable clinical responses.
Key Topics:

Assay Development, Kinome Exploration & and Kinase-Focussed Drug Discovery Principles
Overcoming Tumor Resistance, Managing the Tumor Microenvironment, and Improving Durability
Exploiting the RAS/MAPK Signalling Pathway
Multikinase and Combination Therapies to Overcoming Resistance
Targeting Established Pharmacological Mechanisms in Alternative Indications Beyond Oncology to Meet Unmet Needs

Don’t miss this opportunity to join & network with 100+ Kinase Biology Experts under one roof, hear from 18+ expert speakers from the space and showcase your work at the Scientific Poster Session.
This meeting is FREE for drug developers and researchers!
To know more visit: https://ter.li/sreltb

11th Alzheimer’s & Parkinson’s DD Summit
2023-02-21 - 2023-02-23 | Hyatt Centric Fisherman’s Wharf, San Francisco, United States
Welcome to the 11th Alzheimer’s & Parkinson’s Drug Development Summit

With a surge in preclinical investment, fresh news of clinical pipeline progressions, and a new era of therapies pending FDA approvals from Biogen, Eisai, and Denali Therapeutics, 2022 has put neurodegenerative drug development back on the map.
Building on the field’s momentum, we are delighted to bring back the 11th Alzheimer’s & Parkinson’s Drug Development Summit, dedicated to overcoming the translational challenges of targeting neurodegenerative mechanisms. This summit will unite neurodegenerative biopharma experts from discovery, preclinical, translational, and clinical backgrounds to showcase the latest breakthroughs in Alzheimer’s, Parkinson’s, and related neurological disorders in 2022 and 2023
To know more visit: https://ter.li/x0w74p

3rd Annual Gene Therapy for Muscular Disorders Summit
2023-02-21 - 2023-02-23 | Hilton Boston Back Bay, 40 Dalton St, Boston, MA, 02115, United States
The past twelve months have seen an unprecedented level of excitement, investment, and progression within the gene therapy for muscular disorders field. As the industry endeavours to move gene therapy treatment through the preclinical and clinical pipeline, in context of reducing toxicity and increasing efficacy, attending the 3rd Annual Gene Therapy for Muscular Disorders Summit has never been so crucial.
This year’s summit will return to Boston to reunite 100+ leading experts in biotech, pharma and academia to continue to develop strategies to deliver safer and more effective gene therapies to muscle cells.
This summit will encompass all aspects of preclinical development and highlight the obstacles in clinical trials, enabling you to address and overcome these challenges.
To know more visit: https://ter.li/wi2a51

6th CAR-TCR Summit Europe
2023-02-21 - 2023-02-22 | ExCeL London, Royal Victoria Dock, 1 Western Gateway, London, E16 1XL, United Kingdom
Join us in London this February to connect with those trailblazing the next wave of CAR and TCR based approaches from pre-clinical development with in vivo engineering and regulatory fast-track strategies to streamlined analytics and automation to make CAR and TCR therapies better, and faster.

Take advantage of cutting-edge innovation from global biopharma leaders in cell armouring, combination approaches and multiplexing gene engineering to improve cell durability and trafficking across allogeneic and solid tumour indications, and leave understanding the technical strategies to build automated, closed-system manufacturing processes to ensure vein to vein time is less than a week.
Promising data-driven case studies outlining next generation product design, clinical trial set-up and manufacturing processes, this meeting is your go-to to comprehensively assess the emerging improvements of CAR and TCR based therapies.
See the full agenda here: https://ter.li/ulbn8o

Retinal Vascular Disease Drug Development Summit
2023-02-21 - 2023-02-23 | Hilton Boston Logan Airport, One Hotel Dr, Boston, MA, 02128, United States
Retinal Vascular Disease Drug Development Summit is an event dedicated to creating a community space dedicated to overcoming the current challenges in drug development for retinal vascular diseases.
The management of these diseases has made remarkable advancements in previous years, but the burden on patients remains high, posing a need to develop novel therapeutics and delivery mechanisms that improve the efficacy and durability of anti-VEGF drugs and beyond.
Providing you with an in-depth coverage of technical insights of anti-VEGF, innovative non-VEGF targeting therapeutics for wet-AMD, DME, DR and RVO, the Retinal Vascular Disease Drug Development Summit will address the specific challenges in utilizing preclinical models for retinal vascular disease, understand key regulatory requirements, and learn how to run effective clinical trials that utilize appropriate endpoints.
Join your colleagues from across R&D, preclinical, translational and clinical teams across the biopharmaceutical industry to streamline your drug development and address the significant and increasing unmet medical need.
To know more visit: https://ter.li/7xp7xc

CRISPR AgBio Congress 2023
2023-02-14 - 2023-02-16 | The Westin San Diego Bayview, 400 W Broadway, San Diego, CA, 92101, United States
The 5th Annual CRISPR AgBio Congress will unite research heads, molecular biologists, regulatory experts, and product developers from large Ag companies, innovative AgBiotechs, academic groups and regulatory bodies to translate share the challenges and opportunities of translating cutting-edge CRISPR technology into a tangible product. If you are working to advance genome-edited crops or plants, this is the must-attend meeting to network with the leading stakeholders progressing the space forward, keep up with the latest technology advances & guidances, and ensure your product is set up to help meet the significant food security challenges the world is currently facing.
To know more visit: https://ter.li/3nrx25

6th Annual 3D Cell Culture Conference
2023-02-08 - 2023-02-09 | London, UK
6th Annual 3D Cell Culture Conference
8-9 February 2022
London, UK
http://www.3D-cellculture.com/PJwl
Sponsored: CelVivo, Promega and Systemic Bio
Conference Co-chairs:
Phillip Hewitt, Global Head of Early Investigative Toxicology, Merck
Rhiannon David, Director, Microphysiological Systems, AstraZeneca
Exploring the implementation of complex in-vitro models for drug development
Join us in February 2023, as SAE Media Group’s 6th annual 3D Cell Culture Conference brings together industry experts from big pharma, regulatory bodies, and cutting-edge researchers to discuss the challenges and drivers of these medical technologies, through case studies of the latest innovations in 3D Cell Culture models, real world examples of clinical applications, and insights into regulatory validation and high throughput screening to give a comprehensive look into this fast growing industry.
3D Cell Culture has gained increasing momentum in the pharmaceutical industry over recent years, with the global 3D Cell Culture market predicted to reach a value of $3.48 Billion by 2028. The pharmaceutical industry globally is realising the growing potential of in vitro tissue models for drug discovery, pathology modelling and validation, safety and toxicity. 3D Cell Culture technology promises to offer increased translatability in models and reduce the costly rates of drug attrition in the discovery process — heralding the next major advance in the discovery of pharmaceuticals.
Event Hashtag: #3DCellCulture2023
Key Conference Highlights:

Discuss the uses of advanced cell technologies for human tissue bioengineering
Uncover the major benefits of 3D modelling in enhancing clinical translation and predictability
Utilise 3D cell culture for personalised drug screening and high-throughput screening over traditional 2D methods
Learn how to implement 3D Cell Culture techniques for antibody and cell and gene therapy discovery process
Delve into advanced case studies looking into organ models: from the blood-brain barrier to liver spheroids

Who Should Attend?
Biotech / Pharma Companies – Investigative toxicologist, Research Scientist, Clinical Pharmacologist, Cell Technologists, Cell and Molecular Scientist, Head of Translational Research, In-Vitro Toxicologists, Director of Drug Discovery, Head of DMPK, Chief Scientific Officer, R&D Scientist, Head of R&D.
Academia – Cell Technology, Stem Cell Sciences, Biochemistry, Protein Technology and Tissue Engineering
Solution Providers – Manager, Head of, CEO, Director, Founder, Account Manager, President, CSO, Executive, Managing Director, Vice President, COO, Biomedical Engineers, Head of External Collaboration
Organisations / Regulatory – Director, Senior Science Advisor, Scientific Officer, Advisor for Toxicology

Healthcare Payment & Revenue Integrity Summit
2023-02-08 - 2023-02-09 | ORLANDO, FLORIDA
Introducing the only industry forum exclusively bringing together key decision-makers, within health insurers and providers, who are responsible for payment and revenue integrity, value-based payment, and networking relations.
At a time when both payers and providers are evaluating and streamlining internal payment and revenue integrity processes, this networking conference has been established to breakdown silos, by promoting discussion between clinical, coding, revenue cycle and payment departments to facilitate the development of efficient, value-based healthcare systems.
To know more visit: https://healthcarepaymentrevenueintegritysummit.com

14th Annual RNA Therapeutics Conference
2023-02-08 - 2023-02-09 | Copthorne Tara Hotel, Scarsdale Place, Kensington, London, W8 5SY, United Kingdom
SAE Media Group invites you to join the 14th Annual RNA Therapeutics Conference, taking place on 8 and 9 February 2023, in London, UK.
Building on the success of previous years, the RNA Therapeutics Conference will bring together industry experts from leading pharma and biotech companies to provide an expert and holistic view on the latest developments of the industry.
RNA therapeutics is a rapidly expanding industry with increasingly growing potential for immunotherapy, personalised medicines, and treatment of genetic, infectious and chronic diseases. This is reflected with the value of the global antisense & RNA therapeutics market expected to reach USD 1.81 billion by 2025, growing at a CAGR of 7.5%.
With Covid-19 rapidly accelerating the RNA landscape through massive regulatory successes, the recent advent of CRISPR, an RNA-guided gene-editing technology, as well as new strides in the delivery of messenger RNA transcribed in vitro, there has been considerable progress in the development of RNA medicines and a major expansion of the RNA-therapeutics field.
This year’s conference will reflect on how the industry has adapted and played a pivotal role in global health over the past year and will discuss the takeaways for future mRNA therapeutic development.
Benefits of attending:

Explore how mRNA leads the way in the genetic medicine space as the next generation of novel drug modalities
Investigate the latest trends in AI drug discovery as a tool for designing novel RNA based therapeutics
Enhance your knowledge of the latest innovations in RNA application and RNA delivery techniques with case studies from BioNTech, Neuway Pharma and Ethris GmbH
Engage in the growing advances and development of novel RNA molecules in the treatment of chronic respiratory, neurodegenerative, and infectious diseases

Who should attend:

Directors of novel RNA therapies
CEOs
Senior and expert scientists
Chief Medical Officers
Chief Technical Officers
Senior Vice Presidents
Global Heads of mRNA R&D
Global Medical Directors
Heads of Translational Medicine
Director, Clinical Pharmacology
Global Head of RNA and Targeted Therapeutics
Clinical Science Director
Head of Biology
Director, Genetic Medicine
Associate Director

EARLY-BIRD RATES:

REGISTER BY 31ST OCTOBER AND SAVE £400
REGISTER BY 3OTH NOVEMBER AND SAVE £200
REGISTER BY 16TH DECEMBER AND SAVE £100

Cancer Neoantigen Vaccines
2023-02-02 | Digital Conference
Over the last few decades, immunotherapy has developed at a rapid rate in the treatment of cancer where neoantigens are the latest breakthrough in tumour immunotherapy. Today, it is still unclear when a cancer vaccine will be made commercially available; what is the latest academic research showing us? What is the industry missing and where are we going?
Join us through a series of inspiring keynote presentations and engaging panel discussions to connect with top pioneers in the space, to discuss the future of cancer immunotherapy and how neoantigens are transforming the field.
Unlock the new era of vaccine development at Cancer Neoantigen Vaccines, a 1-day digital conference taking place February 2, 2023 and discover the path to commercial success with novel approaches toward cancer neoantigen vaccines.
You’ll shape the future of next generation cancer vaccine development with new oncolytic approaches and critical immunotherapy strategies and uncover, key research on targets and evolution, how to successfully enter global markets and the future of personalisation and beyond.
You can expect to uncover methods of identifying true targets and deep dive into the future of machine and deep learning in identifying neoantigens. Plus, you’ll hear successful case studies and promising data on the latest neoantigen vaccine development and gain a deeper understanding of the future of vaccines in personalised medicine. Don’t miss your opportunity to be a part of the discussions with industry experts on their look to the future.
All of this plus much more without leaving your desk! Your digital pass gives you access to the full attendee list with video chat, instant message, and meeting request functionalities to connect with like-minded thought-leaders in the field to expand your network, and access to the content on-demand for 10 working days post-event.

3rd TGF-β for Immuno-Oncology Drug Development Summit
2023-01-30 - 2023-02-01 | Marines Memorial Club and Hotel, 609 Sutter St, San Francisco, CA, 94102, United States
Exploit Understanding of TGF-β Biology, Harness Clinically Validated Biomarkers & Advance Safe & Efficacious Clinical Programs for Maximal Therapeutics Benefit in Immuno-Oncology.
In the past year alone, the field has learnt valuable lessons from the clinical trials and from the wider TGF-β field that will equip the immuno-oncology field with the knowledge needed to supercharge future TGF-β monotherapy or combinational therapeutics for precision medicine.
From uncovering the effects and production of TGF-β in immune, tumor and stromal cells to exploring predictive and pharmacodynamic TGF-β biomarkers for patient identification and assessing the clinical challenges that led to recent clinical failures, the 3rd TGF-β for Immuno-Oncology Drug Development Summit is your one-stop-shop dedicated to harnessing you with the knowledge to unlock the potential of successfully targeting TGF-β.
Tailored with 18+ senior leaders, the 2023 meeting will be taking place in-person for the first time – don’t miss your chance to be in the room for your comprehensive guide on TGF-β in immuno-oncology!
Whether you are new to this field or a seasoned expert, this meeting will provide you with the must-know takeaways from the basic biology to biomarkers to clinical trial design to overcome the clinical setbacks and produce a blockbuster TGF-β therapeutic.
To know more visit: https://ter.li/cjnpgy

2nd HFpEF & HCM Drug Discovery & Development Summit
2023-01-24 - 2023-01-26 | Wyndham Boston Beacon Hill, 5 Blossom St, Boston, MA, 02114, United States
The 2nd HFpEF & HCM Drug Discovery & Development Summit is the definitive industry forum dedicated to propelling drug discovery and development across emerging therapeutics including cell and gene therapies and the implementation of precision medicine.

Shake hands with industry pioneers prioritizing the development of therapeutic treatments to complement the new standard of care with SGLT2 inhibitors and understand how you can leverage advances in biomarkers for early detection of drug efficacy and clinical trial updates to inform your strategic decisions.
Join 80+ biopharma experts in research, cardiovascular, rare disease and precision medicine as they analyze the HFpEF patient population and translational drug development pathway to achieve new commercially viable and clinically accepted therapeutics.
To know more visit: https://bit.ly/3EjK5H3

DDR Inhibitors Summit 2023
2023-01-24 - 2023-01-26 | Hilton Boston Back Bay, 40 Dalton St, Boston, MA, 02115, United States
The 6th DDR Inhibitors Summit is taking place in-person for the first time in 3 years in Boston, MA this January 24 – 26, 2023.
The DNA damage response inhibitor space only continues to grow, with progress being accelerated by a shift in focus onto next-generation targets like PolQ and WRN, moving forward from monotherapies through combining targets and exploiting sensitivity caused by DDRis to enhance other therapies like radiotherapy.
The scope of this year’s meeting is to bring together leading minds in DDRi drug development to exploring these strategies and aim to address issues related to emerging DDR inhibitor resistance and maximizing efficacy, as well as addressing the biggest challenge in the space right now, toxicity.
The 3-day meeting will consist of a comprehensive overview of the DDR space, with over 30+ world class speakers sharing insights preclinical updates, progress in the clinic, solutions to overcoming toxicity and improving patient selection.
Don’t miss out on hearing from the best in the field on how to overcome toxicity and resistance during drug design as well as in the clinic, to maximize efficacy and propel your DDR inhibitors to success.
To know more visit: https://ter.li/40qr50

2nd Annual mRNA-Based Therapeutics Summit Europe
2023-01-24 - 2023-01-26 | TBC – Berlin, Germany
The 2nd Annual mRNA-Based Therapeutics Summit Europe is the only end-to-end mRNA-dedicated meeting in Europe and the largest gathering for mRNA professionals outside of the United States.
Built with biopharmaceutical industry insights, this meeting will unite KOLs from Europe and the rest of the world to delve into the challenges associated with successfully designing and developing the next-generation of mRNA-based vaccines & therapeutics with improved specificity, delivery & efficacy for immuno-oncology, infectious diseases and beyond.
Hear from 35+ pioneering large pharma, biotech, and academic experts who are shaping the landscape of mRNA-based therapeutics and discover how they are addressing the major challenges facing the industry.
With more companies investing in their tools and technologies to innovate processes and technologies to address key challenges such as sequence optimization, cell-specific payload expression, and durability, there has never been a more pivotal time to join European biopharma experts and discuss the following topics.
-Emerging cell-enhancing or protein replacement therapies based on mRNA
-Optimization of analytical and quality control protocols
-Durability, accessibility and immunogenicity challenges of mRNA therapeutics and vaccines
-Enhancement of formulation, process development and manufacturing processes
-Need for clear regulatory path to support the technology whilst enabling speed to market
To learn more, download your copy of the full event guide including all speakers and their session details: https://ter.li/tholw0

Transdermal and Microneedle Drug Delivery
2023-01-23 - 2023-01-24 | London, UK
SAE Media Group’s 2nd Annual Conference
Transdermal and Microneedle Drug Delivery
January 23 – 24, 2023 | London, UK
www.transdermal-microneedle-delivery.co.uk/pharmajournalistel
————————————————————————-
SAE Media Group is proud to present the 2nd annual Transdermal and Microneedle Drug Delivery Conference, taking place on the 23rd to 24th January 2023.

The 2023 Transdermal and Microneedle Drug Delivery Conference will explore real world applications of microneedles in drug delivery and strategies for advanced and user-centric device design. Regulation of transdermal delivery systems will be another key theme addressed, in combination with clinical trial optimization. Engage in the latest innovations in device design, development and formulation, with case studies from expert key opinion leaders of this rapidly accelerating space. Other key areas will be microneedle vaccines and transdermal patches for management of chronic disease.
The two-day agenda offers you peer-to-peer networking with CEO’s, Senior Vice presidents, Directors, Heads of Product Development and many more.
BENEFITS OF ATTENDING:

Engage with senior industry opinion leaders presenting their experiences and case studies in innovative device design and advanced drug product formulation
Gain insights from notified body and competent authority representatives addressing key regulatory requirements
Understand how to optimize your lifecycle management strategy for a commercially successful device
Explore and benchmark against industry advances in device design through case studies and real-world examples

WHO SHOULD ATTEND:

Drug-Delivery Device Developers
Microneedle Device Developers
Transdermal Delivery Developers
Microarray Patch Developers
Medical Device Engineers
Primary Packaging Material Designers
Secondary Packagers
Smart Device Developers
Training Device Developers
Device-Safety Solution Providers
Drug Developers
Transdermal Drug Product Developers

EARLY-BIRD RATES:

BOOK BY 30TH SEPTEMBER AND SAVE £400

Registrations can be made on the event website at: www.transdermal-microneedle-delivery.co.uk/
Targeted Keywords
Transdermal and Microneedle Drug Delivery, transdermal, drug development, regulatory guidelines, pharmaceutical industry, drug delivery, therapeutic sectors, vaccines, Parenteral administration, combination products, primary packaging, sterile injectables, connectivity, human factors, autoinjectors

Spatial Biology for Immuno-Oncology Summit
2023-01-17 - 2023-01-19 | The Westgate Hotel, 1055 2nd Ave, San Diego, CA, 92101, United States
The inaugural Spatial Biology for Immuno-Oncology Summit runs at a crucial moment in time. Spurred on by technological advancement and successful case studies, spatial technologies are set to become increasingly mainstream and accessible. If you’re not already, now is the time to harness spatial technologies to power your immunotherapy research, improve your clinical trials, enhance your biomarker discovery, and streamline your therapeutic development.
Uniting researchers, technology providers, and drug developers, next January join your peers to hear the latest best-practice case studies on operationalizing technology, integrating spatial into the clinic, and developing a robust data analysis pipeline. This meeting will provide an unrivaled opportunity to solve your current spatial challenges to improve your ability to treat disease and identify drug targets in immuno-oncology.
Across 3 jam-packed days of content, led by 20+ immuno-oncology leaders, the Spatial Biology for Immuno-Oncology Summit is your only chance to discover how technologies that put omics and single-cell information in spatial context can improve your ability to treat disease and identify drug targets in immuno-oncology.
Join over 100 key industry stakeholders as they gather and leave no stone unturned to advance the application of this revolutionary technology.
To know more visit: https://bit.ly/3yYeUhw

11th Annual Pharmaceutical Microbiology Conference
2023-01-16 - 2023-01-17 | London, United Kingdom
11th Annual Pharmaceutical Microbiology Conference
16 – 17 January 2023
London, UK
http://www.pharma-microbiology.com/PJwl
Sponsored by: Microgenetics
Co-chairs Di Morris, Clinical Auditor, AstraZeneca and Nigel Cryer, Deputy Director Global Audit, Sanofi
Harnessing Alternative Rapid Microbial Methods for a Successful Contamination Control Strategy

We are delighted to announce SAE’s 11th Annual Pharmaceutical Microbiology Europe Conference taking place in London, UK on the 16-17 January 2023.
Microbiology remains an essential tool for the detection of microorganisms present in biopharmaceutical and pharmaceutical batches. This conference will explore the most pressing topics in this thriving field, from the movement toward process automation and increased regulatory stringency, to the latest technologies in rapid microbiological testing methods and data integrity.
Event Hashtag: #MicrobiologyEurope
Key Highlights for 2023 Conference:

Optimise your contamination control strategy and review the initial impact of Annex 1
Learn how to utilise the latest microbiological methods to modernise your contamination control strategy
Maximise the data output from your environmental and microbial monitoring with proven strategies and technologies
Increase the diversity of your testing methodologies through industry case studies including the recombinant factor C assay and Monocyte Activation Test

Who Should Attend?
Heads of Microbiology, Heads of Aseptic Processing, Global Quality Directors, Heads of GMP Compliance, Quality & Compliance Heads, Microbiology Senior Specialists, Directors of Quality Control Biology, Quality Control Managers, Quality Assurance Managers, Lean Managers, Operations Managers, Heads of Site Compliance, Heads of Sterile Technology, Global Microbiology Analytical Experts, Cleanroom Managers, Regulatory Affairs Managers, Production Managers, Quality Systems Managers
Download the brochure at: http://www.pharma-microbiology.com/PJwl

Pre-Filled Syringes and Injectable Drug Devices Europe
2023-01-10 - 2023-01-12 | London, UK
SAE Media Group’s 15th Annual Conference
Pre-Filled Syringes and Injectable Drug Devices Europe
January 10 – 12 2023 | London, UK
http://www.pre-filled-syringes.com/pharmajournalist
————————————————————————-
The pre-filled syringes industry is growing at an exponential rate with innovations in parenteral delivery device development to increase patient centricity, aid self-administration and deliver biologics that have large-volumes and novel formulations. This year’s conference will explore the exciting advances in the combination product drug delivery space and a future outlook exploring how pharma, device developers and regulators can work together to encourage innovation.

SAE Media Group’s 15th Annual Pre-Filled Syringes and Injectable Drug Devices Conference will be bigger than ever, with a pre-conference focus day exploring the advances in PFS design for enhanced drug delivery proceeded by a two-day main conference comprising of morning keynote plenaries and parallel afternoon topic streams as detailed below:

Novel Drug Products and Large Volume Delivery
Sustainability for Injectable Delivery Devices
Primary Packaging Development
Connected Drug Delivery Devices

Topics of discussion will include the latest updates in the combination product regulatory framework, insights into the evolving digital health landscape for connected delivery devices, considerations for the development of primary packaging, utilising platform technology, the delivery of novel drug formulations and large volume drug products, patient centric approaches to device design as well as sustainable approaches for device development.
This event will not only bring you key insights you need to expand and enhance your injectable device portfolio but will also give you the opportunity to network with key players throughout the industry.
Benefits of Attending:

Engage with industry representatives on the latest trends within the pre-filled syringe and injectable device market
Hear about new technological advances in the delivery of large volume drugs
Explore updates to drug device combination product design approaches considering patient preference at the forefront with case studies from big pharma representatives
Understand the latest regulatory requirements from regulatory experts surrounding medical devices and digital health
Delve into the considerations for material components for the development of primary packaging
Gain insight into how big pharma are incorporating sustainable approaches into drug device design

Who should attend:
Advanz Pharma; AstraZeneca; Balda Medical GmbH & Co. KG; Bayer AG; Bayer Pharma; BD Medical; BD Medical – Pharmaceutical Systems; Becton Dickinson (BD); Boehringer Ingelheim; Boehringer Ingelheim GmbH & Co. KG; Boehringer Ingelheim Pharma GmbH & CO KG; Boehringer Ingelheim Pharma Gmbh & Co. Kg; BSI; BSI Group; Chiesi Ltd; Crux Product Design Ltd; DCA Design International; Device Development; Dr.Reddys; GlaxoSmithKline; GSK; Hoffmann-La Roche; Horizon Therapeutics GmbH; Ichnos Sciences; Janssen Pharmaceutical Companies; Johnson & Johnson; Johnson & Johnson (Janssen Pharmaceutical); Medincell; Merck Group; Midas Pharma Gmbh; Nemera; Novartis; Novo Nordisk; Novo Nordisk A/S; Owen Mumford; Pfizer; Pfizer UK; PharmaEssentia; Prescient Healthcare Group; RAUMEDIC AG; Sanofi; SCHOTT AG; SPM MEDICARE PVT LTD, INDIA; Sustainable Healthcare Coalition; Takeda; Teva; Teva Pharmaceuticals; Teva Pharmaceuticals Industries Ltd.; Teva, Combination Products; TUV Italia SRL; TUV SUD Japan Ltd.; TUV SUD Product Service GmbH; University of Liverpool; University of Southern Denmark; Zeon Europe GmbH; Zeon Specialty Materials ;
SAE Media Group offer direct access to key decision makers through tailored sponsorship and exhibitor packages.
For details, please contact Daniele Moreschi on: +44 (0)20 7827 6050 or dmoreschi@smi-online.co.uk
For all delegate enquiries, contact Jamie Wilkinson on: +44 (0) 20 7827 6136 or jwilkinson@smi-online.co.uk
About SAE Media Group Conferences:
SAE Media Group Conferences connects global communities with focused networking conferences. We provide our customers with solutions through industry knowledge and collaboration that enables our attendees to return to their organisations better equipped to overcome their key business challenges. Our key events focus on Defence and Aerospace, Pharmaceutical and Medical. Each year we bring together over 5,000 senior business professionals at our conferences. http://www.smgconferences.com
SAE Media Group (SMG), a subsidiary of SAE International, reports the latest technology breakthroughs and design innovations to a global audience of nearly 1,000,000 engineers, researchers, and business managers. SMG provides critical information these professionals need to develop new and improved products and services.

PURIFY – Chromatography Purification Conclave
2022-12-14 | Taj Skyline, Ahmedabad
PURIFY Conclaves are pioneers of dedicated conferences in India that will help stretch possibilities, be it discovery, development or scaleups!
The pharmaceutical industry continues to dwell deeper into the growing possibilities for chromatography purification; the PURIFY conclaves touches upon diverse aspects of chromatography purification.
The attendees at PURIFY get exposed to a myriad of topics that could change the way they work…change the way they purify. New separation techniques and approaches, niche topics, deeper understanding of preparative and process chromatography and allied fields, and upcoming application areas that will provide quality substance to the discerning scientists. So, if you wish to get that additional gram, which is purer, in as less a time, with minimal resources…there will surely be something for you at PURIFY conclaves!
The annually occurring PURIFY Conclave is an initiative by Custage Marketing Solutions LLP, a Mumbai based company.
The PURIFY conclave is attended by analytical and research chemists, scientists with scale-up and process development knowledge, managers, group heads, natural product purification experts, experts from quality and manufacturing, academicians, policy makers, supply chain heads etc. of this pharmaceutical – APIs, peptides, proteins, oligonucleotides, chiral molecules, bio-pharmaceutical, fine chemicals, environmental studies, food and beverage, polymers, biotechnology, cosmetics and fragrance to understand the advancements in chromatography platforms.
So, the purification expert in you will surely get answers to the daily challenges faced for you in your laboratories. And what’s more, the knowledge comes to you from dignitaries who are institutions on their own in chromatography purification and related.

Advanced Wound Care Summit Europe 2022
2022-12-13 - 2022-12-14 | TBC, Berlin, Germany
The Advanced Wound Care Summit EU is the first industry-led, EU-focused, forum on commercialising innovative wound care products. How will you comply with the EU MDR? What is the best strategy to ensure widespread clinical adoption and reimbursement? What can you do to engage with other wound care companies, for collaboration or acquisition? Expect to hear from, and network with, wound care leaders, across large wound care companies and SMEs.
Find out how C-level Executives, VPs and Directors of R&D are tackling the most pressing industry challenges, seizing growth opportunities, and building innovation. Whether an executive, investor, researcher or healthcare professional, this meeting offers an empowering environment that allows you to secure your stake in the AWC market.
To know more visit: https://hubs.ly/Q01lR8NX0

2nd Synthetic Biology-Based Therapies Summit
2022-12-13 - 2022-12-15 | (exact venue TBC), Boston, US.
Returning for a second year the Synthetic Biology-Based Therapies Summit is the leading industry-defining forum made exclusively for leaders in the synthetic and engineered biology space, focusing on the technical challenges that lie ahead in the path towards commercialization.
Download the event guide to find out more
Learn from industry trailblazers at Arsenal Biosciences, bit.bio, Moderna, MIT, Novome Bio, Strand Therapeutics, Synlogic and more, to support your efforts in developing safe and effective synthetic biology-based therapeutics.
Join Global Innovators to:

Learn from the academics that are driving the future of synthetic biology development with the National Institute of Standards & Technology and Massachusetts Institute of Technology
Leverage novel control strategies for improved therapeutic efficacy and patient safety with Arsenal Biosciences, bit.bio, CHAIN Biotechnology and Strand Therapeutics
Employ synthetic biology techniques in the clinic, hearing about a variety of therapeutic applications with Kite Pharma: A Gilead Company, Novome Biotechnologies and Senti Biosciences
Apply computation, artificial intelligence, and machine learning to engineered and synthetic biology with Lawrence Berkley National Laboratory and Sanofi
Explore the potential for engineered biology as a tool for drug discovery and development with LifeMine Therapeutics and Merck & Co.

5th Annual RNA-Targeted Drug Discovery Summit
2022-12-13 - 2022-12-15 | Boston Park Plaza, 50 Park Plaza, Boston, MA, 02116, United States
RNA-Targeted Drug Discovery Summit returns for its fifth year this December. Join the summit for deep dive into new and emerging topics such as:

Induced Proximity as a new class of “targeted RNA degraders”
Next-generation probing and screening technologies to accelerate HIT identification and validation
Biophysical, biochemical, and cell-based assay development strategies to identify and optimize small molecules interacting with RNA
In vivo pharmacology, safety, and efficacy early considerations to accelerate the transition from discovery to pre-clinical and clinical development

View the event program here: https://ter.li/7qs017
Secure your place here: https://ter.li/jlh128
If you have any further questions regarding the summit, please contact us at info@hansonwade.com.

3rd TIGIT Axis Therapies Summit
2022-12-07 - 2022-12-08 | Digital Event
In the context of a need to regroup and accelerate practice-changing cancer immunotherapies towards approval and to patients in need, the 3rd TIGIT Axis Therapies Summit returns to reunite large pharma, innovative biotechs and pioneering academics to discuss the full range of next-generation TIGIT axis targeted drug modalities and maximize TIGIT-axis targeting in the solid tumor, blood cancer and non-oncology setting.
Covering deciphering the mechanistic intricacies underlying TIGIT axis signaling, defining combination partners that improve efficacy and strengthen TIGIT targeted pipelines, exploring novel drug designs in terms of Fc functionality and IgG type, identifying molecular signatures relevant to the tumor microenvironment and periphery to incorporating unique pharmacology properties into trial design, this is your comprehensive guide for addressing the unique challenges of TIGIT axis targeted drug development and powering up your pipelines.
This year’s sharp two-day agenda leans into the clinical headwinds faced by so many immune checkpoint targets. As the space regroups, join the conversation to build meaningful partnerships and maximize the clinical and commercial success of the next generation of TIGIT axis targeted drugs.
Find out more here: https://ter.li/ir0syg

2nd Next-Generation Food Allergy Drug Development Summit
2022-12-06 - 2022-12-07 | Hilton Boston Logan Airport, One Hotel Dr, Boston, MA, 02128, United States
The field of food allergy therapeutics is continuing to boom as companies flood the news with fresh IND clearances and clinical readouts. The race to market for the next food allergy therapy is well and truly on, but access to funding and large patient cohorts, along with the need for novel IgE biomarkers and better diagnostics (to name a few challenges) are holding drug developers back from even faster progress.
The 2nd Next-Generation Food Allergy Drug Development Summit is reuniting this December as the only industry-focused meeting dedicated to unveiling the complexities of food allergies with novel oral immunotherapies, antibody-based therapeutics and microbiome-based approaches to accelerate ground-breaking treatments for the ever-increasing unmet medical need.
Join us in-person for the first time in Boston as the food allergy community comes together to unravel the complex regulatory landscape, identify and validate novel clinical biomarkers to aid patient selection and explore novel routes of administration to innovate long-lasting, next-generation treatments.
To know more visit: https://bit.ly/3GlzzRp

4th Annual Targeted Radiopharmaceuticals Summit Europe
2022-12-06 - 2022-12-08 | Leonardo Royal Amsterdam, Paul van Vlissingenstraat 24, Amsterdam, 1096 BK, Netherlands
The long-awaited 4th Annual Targeted Radiopharmaceuticals Summit Europe is returning in-person in Amsterdam on December 6-8, 2022!
As the only devoted meeting for large pharma, biotech and pioneering academics, this meeting unites key stakeholders under the mutual and ambitious objective of advancing radioligand candidates to commercialisation through rigorous clinical rationale and reliable supply chain design.
Download the full Event Guide to learn what the 29+ expert speakers will present on, including:

Meeting the newest contenders to enter the field including Ariceum Therapeutics and TRIMT
Discovering new targeting systems that are opening avenues to treating more cancers with Tagworks and Ratio Therapeutics
Getting the most up-to-date information on current radionuclide stocks and how the world’s leading isotope producers are increasing their production and variety of products with Duke University
Enhancing your trial design to conduct the most rigorous trials with help from leading clinical stage companies with Oncoinvent
The ability to showcase your work and meet new people across dedicated sessions and have the meetings that will help you build vital collaborations

Access the official Event Guide here to see the complete agenda and speaker line up.

5th Commercializing Clinically Validated Digital Therapeutics Summit
2022-12-06 - 2022-12-08 | Hyatt Regency Boston, One Ave. de Lafayette, Boston, MA, 02111, United States
The 5th Commercializing Clinically Validated Digital Therapeutics Summit, designed with DTx companies, pharma and clinicians, will return this December to address the industry’s major challenges such as improving user experience, clinical trial development, and standing out in a crowded market through open discussion and case-study led presentations.
Whether you’re a veteran at commercializing clinically validated digital therapeutics, looking for partnerships, or a new entrant to the field, you’ll leave this conference with practical lessons and essential connections needed to supercharge DTx commercial ambitions across 2022 and beyond.
To know more visit: https://ter.li/5e6hqd

4th Annual Cell Therapy Analytical Development Summit
2022-12-05 - 2022-12-07 | Hilton Boston Logan Airport, One Hotel Dr, Boston, MA, 02128, United States
Cell Therapy Analytical Development Summit US is back for its fourth year, taking place in Boston (December 5-7). Join 180+ colleagues from analytical development, process development, quality control and regulatory affairs, to standardize analytical testing and take advantage of unrivalled content across:

3-days
6 deep-dive workshops
2 tracks

Seize an unmatched opportunity to delve into cell potency, safety, viability, sterility and more across both autologous and allogeneic cell therapy products.
Please use this URL – https://ter.li/ghwxjk

4th Annual Gene Therapy for Neurological Disorders
2022-12-05 - 2022-12-08 | The Westin Seaport District, 425 Summer St, Boston, MA, 02210, United States
Delivering the Next Wave of Gene Therapies to the CNS
With systemic toxicity challenges plaguing the AAV field, direct administration for CNS indications creates an ideal target for gene therapy. This is an exciting year for the neurological space with clinical data to show and new biotechs coming out of the woodwork to release the next wave of gene therapies with more advanced CNS targeting for a wider selection of neurological targets.
The 4th Annual Gene Therapy for Neurological Disorders Summit will unite gene therapy developers with an industry-focused agenda across 4 days and 2 dedicated tracks of content to solve the preclinical, translational and clinical challenges of targeting a wide range of neurodevelopmental and neurodegenerative disorders with both ‘first’ and ‘next’ generation gene therapies.
Join the expanding audience of gene therapy experts to:

Streamline CNS drug delivery devices for improved brain biodistribution
Discover novel vectors for CNS specificity & tropism
Optimize gene therapy strategy for pediatric & adult neurological disorders

To know more visit: https://ter.li/rluqrj

PAT & Real Time Quality Summit
2022-12-01 - 2022-12-02 | Hilton San Diego Gaslamp Quarter, 401 K Street, San Diego, CA, 92101, United States
The time has come to remove the pharmaceutical industry’s reliance on archaic off-line testing and embrace the cost and speed-to-market savings of online control and real-time product quality.
The PAT market is projected to reach USD 4.96 Billion by 2027, spurred on by the recent ICH Q14/ Q2 (R2) guidelines, there has never been a more opportune moment to leverage regulator’s support of QbD, real-time control, and process intervention to achieve meaningful business impact in your organization, through reduced downtime, manufacturing footprint, ease of scale-up and product consistency for approval.
Whether you’re applying in small molecules, biologics, or ATMP, bridge the gap in technology, culture, or regulatory experience that is the bottleneck to your organization saving an average 50% reduction in process cycle time and winning speed to market, with the strategical implementation of smart process analytical technologies and quality by control (QbC).
Join a senior community of experts in process development, manufacturing, regulatory & quality to understand how to monitor critical quality attributes with reactive and predictive control systems and discover novel PAT technologies as the industry moves the needle toward realizing real-time release.
To know more visit: https://ter.li/080rbc
